floblu, as you probably know, GTC’s ADCC patent application is cited in the ReadMeFirst, which Mr. Pre_Clinical claims to have read. What I’m trying to say is that I don’t think Pre_Clinical is looking for information. Regards, Dew
What am I looking for then, guy? Look Ive been more than cordial with you, but you're comments, quite frankly, have been rather glib. And it seems like you take a lot of what the company says at face value. That doesn't sound like good Due Diligence to me. In fact, you didn't know until today the reason why the company's lead compound has a shorter half life than the plasma material. You're handle says "lets talk biotech" but it certainly doesn't seem that way.
Market Data 
Markets 
AI
